Skip to main content
Log in

Managing innovation: university-industry partnerships and the licensing of the Harvard mouse

  • Patents
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

DuPont's Oncomouse patent licensing program continues to cause a stir in academia and industry.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Study on research universities funded by the European Commission (http://ed.sjtu.edu.cn/rank/rank-2003.mht).

  2. Association of University Technology Managers survey (2000) and Working Together, Creating Knowledge, The University-Industry Research Collaboration Initiative (2001).

  3. Campbell, E. et al. Health Affairs 23, 64–76 (2004).

    Article  Google Scholar 

  4. Hall, Z.W. & Scott, C. Science 291, 553 (2001).

    Article  CAS  Google Scholar 

  5. Edwards, M.G. et al., Nat. Biotechnol. 21, 618–624 (2003).

    Article  CAS  Google Scholar 

  6. Associated Press. Uproar over mighty mouse (8 November, 2003).

  7. Marshall, E. Science 296, 1212–1213 (2002).

    Article  CAS  Google Scholar 

  8. Smaglik, P. Nature 403, 350 (2000).

    Article  CAS  Google Scholar 

  9. Memorandum of Understanding between E.I. DuPont de Nemours and Company and Public Health Service (MOU) (http://ott.od.nih.gov/textonly/oncomous.htm).

  10. Gordon, J.W. & Ruddle, F.H. Science 214, 1244–1246 (1981).

    Article  CAS  Google Scholar 

  11. Palmiter and Brinster reported in the scientific literature the first cancer prone transgenic mouse 4 months earlier than Leder and days before the filing of Harvard's patent. Brinster R.L. et al. Cell 37, 367–379 (1984).

    Article  CAS  Google Scholar 

  12. Stewart, T.A., Pattengale, P.K. & Leder, P. Cell 38, 627–637 (1984).

    Article  CAS  Google Scholar 

  13. US Patent 4,736,866.

  14. US Patent 5,925,803.

  15. Grants 1Z01HD000074-4 through 1Z01HD000074-11, awarded by the National Institute of Child Health and Human Development (http://crisp.cit.nih.gov/).

  16. Grossblatt, N. (ed.). Sharing Laboratory Resources: Genetically Altered Mice. Summary of a Workshop Held at the National Academy of Sciences, March 23–24, 1993 by National Research Council, Ch. 4, 21–23 (National Academy Press, Washington, DC, 1994).

  17. Melbourne Herald Sun, Australia. p. 52 (8 November 2003).

  18. Lamb, C. Sacramento Business Journal (3 November 2003).

    Google Scholar 

  19. Heller, A. & Eisenberg, R.S. Science 280, 698–701 (1998).

    Article  CAS  Google Scholar 

  20. See MOU, supra note 9, at Section (1).

  21. See, for example, Cook, G. The Boston Globe (31 May 2002).

  22. See, for example, Policy Guidelines Governing Openness and Freedom to Publish (http://www.spo.berkeley.edu/Policy/ucmemos/publish.html), and Principles Regarding Rights to Future Research Results in University Agreements with External Parties (http://www.ucop.edu/ott/preamble.pdf).

  23. See Memo Operating Guidance on Industry-University Relationships, No. 89-20 (6 June 1989) (http://www.ucop.edu/raohome/cgmemos/89-20.html).

  24. Lawler, A. Science 299, 330–333 (2003).

    Article  CAS  Google Scholar 

  25. AUTM 2000, 2001 and 2002 studies (http://www.autm.net/).

  26. See NIH letter to UC (http://206.151.87.67/docs/OncoMouseDuPont.doc).

  27. Madey v. Duke, 307 F.3d 1351 (Fed. Cir. 2002).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blaug, S., Chien, C. & Shuster, M. Managing innovation: university-industry partnerships and the licensing of the Harvard mouse. Nat Biotechnol 22, 761–763 (2004). https://doi.org/10.1038/nbt0604-761

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0604-761

  • Springer Nature America, Inc.

This article is cited by

Navigation